Why the study?
Does adherence to evidence-based secondary prevention medications reduce the risk of death or reinfarction in patients surviving a myocardial infarction?
Cohort (n=14,843)
Yes
Does adherence to evidence-based secondary prevention medications reduce the risk of death or reinfarction in patients surviving a myocardial infarction?
Answers are grounded in this paper and cite their sources.
Higher adherence to evidence-based secondary prevention medications, specifically statins, clopidogrel, and ARB/ACE inhibitors, is associated with a significantly lower risk of death or reinfarction in post-MI patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jánosi et al. (2017) conducted a cohort in Myocardial infarction (n=14,843). Adherence to secondary prevention medications (statins, clopidogrel, beta blockers, aspirin, ARB/ACEI) was evaluated on Death or reinfarction (10.1% to 15.8% lower hazard, p=<0.0001).
Synapse has enriched 10 related papers. Consider them for comparative context: